← back to search

Mohamed Adam

Cambridge University Hospitals NHS Foundation Trust · GB
Area of research
Molecular Biology · Cell Biology
Research interest
Research interests include Angiogenesis and VEGF in Cancer, Hippo pathway signaling and YAP/TAZ, Developmental Biology and Gene Regulation, and Axon Guidance and Neuronal Signaling.
h-index
17
citations
851
works
26
NIH funding
primary concept
email

Recent publications

Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study
EClinicalMedicine 2023cited by 55position: middledoi
MPDZ promotes DLL4-induced Notch signaling during angiogenesis
eLife 2018cited by 50position: middledoi
Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis
Oncogene 2018cited by 33position: middledoi
Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching
Frontiers in Pharmacology 2018cited by 32position: middledoi
BRCA2 is a Novel Regulator of Endothelial Cell Function and Apoptosis Following Oxidative Stress
Atherosclerosis Supplements 2018cited by 5position: firstdoi
Author response: MPDZ promotes DLL4-induced Notch signaling during angiogenesis
2018cited by 1position: middledoi
Loss of Mpdz impairs ependymal cell integrity leading to perinatal‐onset hydrocephalus in mice
EMBO Molecular Medicine 2017cited by 71position: middledoi
SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status
Cell Cycle 2015cited by 34position: firstdoi
Soluble Notch ligand and receptor peptides act antagonistically during angiogenesis
Cardiovascular Research 2015cited by 30position: middledoi
Synaptojanin-2 Binding Protein Stabilizes the Notch Ligands DLL1 and DLL4 and Inhibits Sprouting Angiogenesis
Circulation Research 2013cited by 104position: firstdoi
No Evidence for a Functional Role of Bi-Directional Notch Signaling during Angiogenesis
PLoS ONE 2012cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andreas Fischer · Universitätsmedizin Göttingen7 papers (2012–2018)Iris Moll · Cancer Research Center5 papers (2015–2018)Anja Feldner · BioNTech (Germany)5 papers (2012–2018)Fabian Tetzlaff · German Cancer Research Center4 papers (2017–2018)Hellmut G. Augustin · Heidelberg Engineering (Germany)3 papers (2012–2015)Thomas Korff · University Hospital Heidelberg2 papers (2012–2017)Mohammad Qadura · McMaster University2 papers (2018–2018)Juan Rodríguez‐Vita · Cancer Research Center2 papers (2018–2018) · 2 papers (2018–2018)Caroline Berger · Université Laval2 papers (2013–2015)Tanya Narang · York University2 papers (2018–2018)Kim A. Connelly · Hospital for Sick Children2 papers (2018–2018)Joycelyn Wüstehube‐Lausch · BioNTech (Germany)2 papers (2013–2018) · 2 papers (2018–2018)Shamini Murugavel · York University2 papers (2018–2018) · 2 papers (2018–2018)Ralph Klose · Heidelberg University2 papers (2015–2018)Krishna K. Singh · McMaster University2 papers (2018–2018) · 2 papers (2018–2018)Sonja Matt · German Cancer Research Center1 papers (2015–2015)